Browsing by Author "Calvet, Claudia M."
Now showing items 1-9 of 9
-
Binding Mode and Potency of N‑Indolyloxopyridinyl-4- aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
Vieira, Debora F. et al. | Date Issued: 2014 -
Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
Choy, Jonathan W. et al. | Date Issued: 2013 -
A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease
Olivieri, Bianca P. et al. | Date Issued: 2010 -
Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction
Calvet, Claudia M. et al. | Date Issued: 2012 -
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
Debnath, Anjan et al. | Date Issued: 2017 -
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents
Saccoliti, Francesco et al. | Date Issued: 2019 -
Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways
Wozniak, Jacob M. et al. | Date Issued: 2020 -
Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents
Choi, Jun Yong et al. | Date Issued: 2013 -
SB-431542, a transforming growth factor β inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion
Waghabi, Mariana C. et al. | Date Issued: 2007